SAM
BMY icon

Strategic Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Strategic Asset Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$14K Hold
200
– – 0.02% 312
2022
Q2 		$15K Hold
200
– – 0.02% 313
2022
Q1 		$15K Hold
200
– – 0.02% 321
2021
Q4 		$12K Sell
200
-800
-80% -$46.9K 0.02% 343
2021
Q3 		$59K Buy
+1,000
New +$65.9K 0.08% 138

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Strategic Asset Management's BMY Position: Q3 2022 in Review

Strategic Asset Management held its Bristol-Myers Squibb (BMY) position steady in Q3 2022 at 200 shares worth $14K. The position accounts for 0.02% of the portfolio, ranked #312.

Strategic Asset Management first reported a position in BMY in Q3 2021 and has held it in 5 quarters since. The position peaked at $59K in Q3 2021. 2,469 funds tracked by Wall St. Rank hold BMY as of Q3 2022.

  • Strategic Asset Management held 200 shares of Bristol-Myers Squibb worth $14K as of Q3 2022.
  • Strategic Asset Management left its Bristol-Myers Squibb share count unchanged in Q3 2022.
  • Bristol-Myers Squibb made up 0.02% of Strategic Asset Management's portfolio in Q3 2022, its #312 holding.
  • Strategic Asset Management first reported a position in Bristol-Myers Squibb in Q3 2021 and has held it in 5 quarters since.
  • Strategic Asset Management's Bristol-Myers Squibb position peaked at $59K in Q3 2021.
  • 2,469 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.

Based on Strategic Asset Management's 13F filing for Q3 2022, filed 1 Nov 2022.